Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)

描述(由申请者提供)：范德比尔特-埃默里-康奈尔-杜克联盟(VECDor)为Fogarty全球健康研究员计划带来了经验丰富的机构的大量和互补的专业知识。范德比尔特全球卫生研究所(VIGH)自2007年以来一直担任Fogarty国际临床研究学者和研究员(FICRS-F)计划支持中心，与87个合作机构合作，培养来自美国和27个中低收入国家(LMIC)的419名经过竞争挑选的博士后和博士后学员。主题包括传染病、癌症、心脏病和肺病、中风、糖尿病、营养、行为和精神健康问题(包括药物滥用)、妇女和儿童健康、眼科疾病、口腔健康、神经病学和动物-人类健康。VECDor经验丰富的全球健康导师已经在美国和LMIC合作机构合作，这些机构被选为非洲(肯尼亚、赞比亚、坦桑尼亚、卢旺达)、亚洲(印度、中国、越南)、拉丁美洲(巴西、墨西哥)和加勒比海(海地)资金充足的多样化研究地点。利用高效的支持中心，最大限度地将资金投向研究培训，并利用多种财务和实物联合资金来源，我们将与超过68个T32和其他由NIH资助的培训项目以及少数族裔机构合作伙伴联系起来，挑选和部署80至100名在研究职业生涯中有突出前景的美国和LMIC学员。VECDor将在整个联盟范围内实施战略指导和学员支持计划，包括在现场部署之前的大量准备阶段，并在研究年度结束后继续，以确保最高质量的研究出版物和科学会议演示，并确保学员在获得研究和职业发展补助金方面取得最大成功。研究主题将涉及受训者和NIH研究所和中心感兴趣的所有主题和地理领域，强调传染病和非传染性疾病。我们将使用FIC的CareerTrac系统，通过长期监测和评估(M&E)计划来记录该计划的影响，该计划跟踪所有研究员的职业方向和产出，例如未来就业、K补助金、研究补助金、科学演示和出版物。我们将进一步完善我们现有的基于网络的工具，以共享知识，促进本地和全球网络，并加强和维持全球卫生研究员和校友的临床研究技能。我们已经促成了大量的机构和现场联合资金，以利用NIH的资源。VECDor建立在我们美国和全球合作伙伴的相互尊重以及我们在研究、创新和指导方面的集体记录的基础上。结合我们最近在研究培训计划管理方面的丰富经验、在具有全球意义的重大疾病方面强大的研究资助基础、知名的国际研究培训合作伙伴和地点以及增强的机构联合资助承诺，VECDor将继续培养21世纪全球卫生研究队伍的关键成员，就像我们在现有的FICRS-F计划中所做的那样。

DESCRIPTION (provided by applicant): The Vanderbilt-Emory-Cornell-Duke Consortium (VECDor) brings the substantial and complementary expertise of experienced institutions to the Fogarty Global Health Fellows Program. The Vanderbilt Institute for Global Health (VIGH) has served as the Fogarty International Clinical Research Scholars and Fellows (FICRS-F) Program Support Center since 2007, working with 87 partner institutions to nurture 419 competitively chosen pre- and postdoctoral trainees from the US and from 27 low- and middle-income countries (LMICs). Topics have included infectious diseases, cancer, heart and lung disease, stroke, diabetes, nutrition, behavioral and mental health issues (including substance abuse), women's and children's health, ophthalmic disease, oral health, neurology, and animal-human health. VECDor's highly experienced global health mentors are already working together in the US and LMIC partner institutions, selected as diverse, well-funded research sites in Africa (Kenya, Zambia, Tanzania, Rwanda), Asia (India, China, Vietnam), Latin America (Brazil, Mexico), and the Caribbean (Haiti). Using a highly efficient support center that maximizes the direction of funds to research training, and leveraging multiple sources of financial and in-kind co-funding, we will link with more than 68 T32 and other NIH-funded training programs and with minority institution partners to select and deploy 80 to 100 US and LMIC trainees with outstanding promise for research careers. VECDor will implement a strategic mentoring and trainee support plan across the consortium, including a substantial preparation phase prior to field deployment and continuing after the research year is completed, to ensure the highest quality research publications and scientific meeting presentations, and maximum trainee success in obtaining research and career development grants. Research themes will address all topic and geographical areas of interest to trainees and NIH Institutes and Centers, emphasizing both communicable and non-communicable diseases. We will document the Program's impact through a long-term monitoring and evaluation (M&E) plan that tracks the career directions and outputs of all Fellows, using FIC's CareerTrac system, e.g., future employment, K grants, research grants, scientific presentations, and publications. We will further refine our existing web-based tools to share knowledge, foster local and global networking, and strengthen and sustain clinical research skills among global health fellows and alumni. We have brokered substantial institutional and site-based co-funding to leverage NIH resources. VECDor is built on the mutual respect of our US and global partners and our collective track record of research innovation and mentorship. Combining our extensive recent experience in research training program management, robust research funding bases in major diseases of global significance, renowned international research training partners and sites, and enhanced institutional co-funding commitments, VECDor will continue to nurture key members of the global health research workforce of the 21st century, as we have done within the incumbent FICRS-F program.